Explore the Global Cyclic Olefin Polymer (COP) Injectable Vials Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Cyclic Olefin Polymer (COP) Injectable Vials Market

Key Insight

FMI opines the cyclic olefin polymer (COP) injectable vials market was valued at USD 484.0 million in 2025. Sales are expected to reach USD 520.0 million in 2026 and USD 1,050.0 million by 2036. 2-5 mL is poised to lead by Capacity with 41.0% share in 2026 and Biologics is estimated to command by Application with 47% in 2026.

March 11, 2026

Nandini Roy Choudhury

250 Pages

Cite this Report

Cyclic Olefin Polymer (COP) Injectable Vials Market

https://www.futuremarketinsights.com/reports/cyclic-olefin-polymer-cop-injectable-vials-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Aptar
Gerresheimer
Mitsubishi Gas Chemical Company
Carl-Zeiss-Stiftung
TOPAS Advanced Polymers
West Pharmaceutical Services
Zeon Corporation

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Cyclic Olefin Polymer (COP) Injectable Vials Market

Key Players

Similar Industry Reports